What are the main clinical trials for Zomig (zolmitriptan)?
Zomig is the brand name for zolmitriptan, a medicine used to treat migraine attacks. However, the specific “Zomig clinical trials” you’re looking for (for example, early pivotal studies vs. later studies in certain populations) depend on the trial number, sponsor, or the exact condition being studied (acute migraine vs. prevention, adults vs. adolescents, oral vs. nasal formulations).
If you share any of the following, I can narrow to the correct trial reports:
- the formulation you mean (Zomig tablets, orally disintegrating tablet, or Zomig nasal spray)
- the trial phase (Phase 2/3, etc.) or the year
- the sponsor/company name
- a NCT number (ClinicalTrials.gov)
Is there newer clinical-trial activity for Zomig, or is it mostly older data?
Zomig (zolmitriptan) has been on the market for many years, so a lot of the best-known clinical evidence comes from earlier Phase 3 development studies that established efficacy for acute migraine symptoms. Newer trials—when they exist—tend to focus on things like:
- comparing formulations (e.g., nasal vs. oral for speed)
- specific dosing strategies
- subgroups (adolescents, elderly, or patients with medication-overuse headache)
To identify the exact set of “current” trials, you’ll need the formulation or trial identifier.
Are there trials comparing Zomig with other triptans?
Migraine trials often compare outcomes such as pain relief at 2 hours and recurrence rates across different triptans (like sumatriptan, rizatriptan, etc.). Whether a given Zomig trial includes direct head-to-head comparisons depends on the individual study protocol.
If you tell me which comparison you care about (for example, “Zomig vs Maxalt”), I can help target the right trial evidence.
What outcomes do Zomig migraine trials usually measure?
In acute migraine studies for triptans, endpoints commonly include whether patients achieve:
- pain relief and/or freedom from headache after a fixed time after dosing
- improvement in nausea and light/sound sensitivity
- the need for rescue medication
- rates of headache recurrence after initial improvement
If you want, tell me the timepoint you care about (often 2 hours) and the formulation, and I can align that to what the trials typically report.
How do I find the exact Zomig trial publications or registry entries?
If your goal is to locate the exact clinical trial records, the fastest path is usually:
1. identify the formulation and dose (tablets vs ODT vs nasal spray)
2. use that to search for the corresponding Phase 3 program on ClinicalTrials.gov
3. match results papers by sponsor, NCT number, and publication year
If you paste an NCT number or a link you already have, I can interpret the trial details (design, endpoints, and results) in plain language.
---
Source